SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs >

NanoViricides Inc. (NNVC)

Add NNVC Price Alert      Hide Sticky   Hide Intro
Moderator: SHORT CABAL, NotAsBigKahuna, NewMoney, drkazmd65
Search This Board: 
Last Post: 3/29/2017 10:41:42 AM - Followers: 467 - Board type: Free - Posts Today: 5

NanoViricides, Inc (NNVC)

Company Address:
135 Wood St, Suite 200
West Haven, CT 06516
Phone:  203-937-6137
Fax:  203-859-5095
CIK:  0001379006
NanoViricides, Inc. is a development stage company with a unique nanomedicine technology. The Company is developing nanotechnology-based biomimetic anti-viral medicines, that we call "nanoviricides®". 
A "nanoviricide" is an antiviral agent designed by the Company to fool a virus into attaching to this agent in the same way that the virus normally attaches to receptors on a cell surface. Once attached, the flexible nanoviricide glob would wrap around the virus and trap it. In the process, the virus could lose its coat proteins that it needs to bind to a cell. The virus is thus neutralized and effectively destroyed. Nanoviricides are designed to complete the task of dismantling the virus particle without immune system assistance.
Thus nanoviricides represent the next great advance in "Immunotherapeutics" (antibodies and vaccines,) the well established antiviral strategies. Viruses have developed smart strategies to derail immune system function. This results in failure of antibodies and vaccines.
The nanoviricide technology attempts to circumvent virus escape that results from natural changes in virus structure. Despite all such changes, the cell receptor to which a virus binds remains the same. Nanoviricides mimic this conserved feature of virus binding to its host cell receptor. If a virus "escapes" a properly designed nanoviricide, it would have a reduced ability to attach to the cell receptor and would have become much less pathogenic in the process.
Recent News:

Micrographic images of nanoviricide micelles in action against Murine Cytomegalovirus:

SEC Filings:
Share Structure:  See SEC filings for current share structure
Investor Relations:
Amanda Schuon, 310-550-7200


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
NNVC News: Securities Registration Statement (simplified Form) (s-3) 03/01/2017 06:10:07 AM
NNVC News: NanoViricides Files Quarterly Report for Period Ending 2016-12-31 02/16/2017 07:00:00 AM
NNVC News: Quarterly Report (10-q) 02/14/2017 06:02:28 PM
NNVC News: Current Report Filing (8-k) 02/13/2017 05:33:10 PM
NNVC News: NanoViricides Reports the Company's Director Dr. Boniuk Converted Series B Debenture to Equity Effectively Raising $5M in New... 02/13/2017 07:00:00 AM
#129330  Sticky Note What happened to all the "good news" from arvitar 01/23/17 04:45:44 PM
#128296  Sticky Note When someone claims to have cured the "near arvitar 12/26/16 02:27:41 PM
#126117  Sticky Note A solid step forward: NanoViricides Signs Agreement drkazmd65 10/31/16 07:46:04 AM
#120585  Sticky Note Well Said! MJJONES 04/28/16 08:35:40 PM
#130778   NIH awarded more than $3 MILLION in SBIR arvitar 03/29/17 10:41:42 AM
#130777   Seems reasonable that Moffat or anyone else would arvitar 03/29/17 09:46:24 AM
#130776   Is this one of those questions where you Its_lose_not_loose 03/29/17 09:25:03 AM
#130775   Just another instance of glorifying a lifetime criminal Its_lose_not_loose 03/29/17 09:23:29 AM
#130774   JUDGING DR. MOFFAT ON THE BASIS OF ONLY Trendliner 03/29/17 07:32:32 AM
#130773   Yikes. Yes, you may be biased as JG36 03/28/17 11:21:14 PM
#130772   My prophecies are even more accurate than puerile JG36 03/28/17 11:08:51 PM
#130771   A TOTALLY BIASED BEARISH VIEW OF MOFFAT Trendliner 03/28/17 10:13:52 PM
#130770   Anyone know if Moffat is one of the arvitar 03/28/17 09:35:33 PM
#130769   Your prophecies are much more accurate than the Its_lose_not_loose 03/28/17 08:48:39 PM
#130768   I'm sure Moffat is smart and knowledgeable about arvitar 03/28/17 05:15:10 PM
#130767   Good info. She seems like the perfect person Its_lose_not_loose 03/28/17 05:02:30 PM
#130766   Like a prophet: JG36 03/28/17 04:34:18 PM
#130765   - Moffat hasn't had any work published from arvitar 03/28/17 03:38:44 PM
#130764   Non sequitur. NNVC has hired top shelf Its_lose_not_loose 03/28/17 03:27:18 PM
#130763   ONE OF THE BULLS' STRONGEST HAT HOOKS IS Trendliner 03/28/17 03:10:47 PM
#130762   Who knows what it really means. arvitar 03/28/17 01:50:23 PM
#130761   That email exchange could have happened 6 years JG36 03/28/17 01:45:01 PM
#130760   Every statement of Seymour is provably complete nonsense. arvitar 03/28/17 01:42:47 PM
#130759   Just copyin' and pastin'... loanranger 03/28/17 01:29:10 PM
#130758   "The Company has sufficient capital to continue its arvitar 03/28/17 12:27:20 PM
#130757   Latest data from NNVC shows $19 million cash leifsmith 03/28/17 12:22:31 PM
#130756   NNVC will run out of money in about arvitar 03/28/17 11:53:37 AM
#130755   Company strategy highly credible. No near term catastrophes leifsmith 03/28/17 11:51:18 AM
#130754   IN FACT IT DOES SEEM CREDIBLE Trendliner 03/28/17 11:06:54 AM
#130753   Here we are, at the end of another Its_lose_not_loose 03/28/17 10:53:12 AM
#130752   Seymour's most recent story is that he has arvitar 03/28/17 10:03:29 AM
#130751   And as with every schedule ever put forth arvitar 03/27/17 04:28:10 PM
#130750   Human trials began a month ago. What's JG36 03/27/17 04:15:36 PM
#130749   Realistically, there are only a few remaining potential JG36 03/27/17 04:13:00 PM
#130748   Just a repeat of what happened in 2016 arvitar 03/27/17 02:32:14 PM
#130747   Has Seymour ever said that results from Moffat's arvitar 03/27/17 02:22:54 PM
#130746   Well, I've been laughing for about 6 or Its_lose_not_loose 03/27/17 02:01:17 PM
#130745   Laugh while the laughing is good :-) leifsmith 03/27/17 01:44:06 PM
#130744   It's funny reading all the conjecture about Moffat's Its_lose_not_loose 03/27/17 01:38:11 PM
#130743   Has Seymour ever said that results from Moffat's arvitar 03/27/17 01:11:32 PM
#130742   And, I think concerns about Dr. Moffat's model leifsmith 03/27/17 01:02:17 PM
#130741   Agreed - the path is clear, they just drkazmd65 03/27/17 12:56:13 PM
#130740   What if Moffat is never able to develop arvitar 03/27/17 12:39:58 PM
#130739   This company is on a clear path to leifsmith 03/27/17 12:31:58 PM
#130738   Heard this someplace before. Positive conclusions based on Its_lose_not_loose 03/27/17 11:48:59 AM
#130737   NNVC has a bizarre way of communicating their Its_lose_not_loose 03/27/17 11:42:44 AM
#130736   Has the Moffat lab developed their shingles model arvitar 03/27/17 11:35:48 AM
#130733   Seymour has never said whether or not results arvitar 03/27/17 10:04:15 AM
#130732   Is this one of those questions where you Its_lose_not_loose 03/27/17 09:41:42 AM
#130731   Perhaps... Perhaps its[sic] a fools[sic] errand to share what Its_lose_not_loose 03/27/17 09:39:30 AM
#130730   Has the Moffat lab developed their shingles model arvitar 03/27/17 08:58:01 AM
#130729   Nice catch! I totally missed that one. Its_lose_not_loose 03/27/17 08:39:55 AM
#130728   Moffat seems to be competent; nanoviricides seem to work. leifsmith 03/27/17 08:38:03 AM
#130727   "By the end of the 2nd Q we loanranger 03/27/17 08:18:29 AM